Assessment of 10‐year changes in liver stiffness using vibration‐controlled transient elastography in non‐alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Assessment of 10‐year changes in liver stiffness using vibration‐controlled transient elastography in non‐alcoholic fatty liver disease

Published:2019-05-23 Issue:8 Volume:49 Page:872-880
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Nogami Asako¹,Yoneda Masato²,Kobayashi Takashi²,Kessoku Takaomi²,Honda Yasushi²,Ogawa Yuji²,Suzuki Kaori²,Tomeno Wataru³,Imajo Kento²,Kirikoshi Hiroyuki⁴,Koide Tomoko⁵,Fujikawa Hirotoshi¹,Saito Satoru²,Nakajima Atsushi²

Affiliation:

1. Department of GastroenterologyJCHO Yokohama Central Hospital Yokohama Japan

2. Department of Gastroenterology and HepatologyYokohama City University Hospital Yokohama Japan

3. Department of GastroenterologyInternational University of Health and Welfare Atami Hospital Shizuoka Japan

4. Laboratory of PhysiologyYokohama City University Hospital Yokohama Japan

5. Division of Internal MedicineGraduate School of Dentistry, Kanagawa Dental University Yokosuka Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13349

Reference42 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. NAFLD in Asia—as common and important as in the West

3. The global NAFLD epidemic

4. Nonalcoholic fatty liver disease and cardiovascular disease

5. Long-term follow-up of patients with NAFLD and elevated liver enzymes

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in Transient Elastography with Glucagon-Like Peptide-1 Receptor Agonist Use in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Real-World Retrospective Analysis;Metabolic Syndrome and Related Disorders;2024-06-13

2. Association of neutrophil-to-high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease and liver fibrosis: a nationally representative cross-sectional study by NHANES from 2017 to 2020;2024-05-07

3. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis;Hepatology;2024-03-15

4. Optimizing surveillance of low-risk metabolic dysfunction associated steatotic liver disease using transient elastography;European Journal of Gastroenterology & Hepatology;2024-02-16

5. A scientifically validated combination of garcinol, curcuminoids, and piperine for mild to moderate nonalcoholic steatohepatitis patients—results from a randomized, double-blind, placebo-controlled study;Frontiers in Nutrition;2023-12-14